VA

Vilas Anandrao Mane

Active Director Designated Partner DIN 10437596
DIN 10437596 First appointment Dec 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Vilas Anandrao Mane

Data last updated:

Vilas Anandrao Mane is a Designated Partner at Wishbon Pharmaceuticals Llp (since 2023). The company operates in Pharma.

DIN 10437596
Primary Designation Designated Partner
Industry Pharma
First Appointment 26 Dec 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Dec 20232023Active

Board colleagues of Vilas Anandrao Mane

NameDINCompanyDesignation
Mangla Vishwasrao Patil10437597Wishbon Pharmaceuticals LlpDesignated Partner
Shilpa Vishal Mane08747404Wishbon Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Wishbon Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Vilas Anandrao Mane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vilas Anandrao Mane

Vilas Anandrao Mane currently holds 1 directorship: Wishbon Pharmaceuticals Llp (Designated Partner, since 26 Dec 2023).

Vilas Anandrao Mane was first appointed on 26 Dec 2023 as Designated Partner at Wishbon Pharmaceuticals Llp.

The current boards of Vilas Anandrao Mane's companies include Mangla Vishwasrao Patil (Wishbon Pharmaceuticals Llp), Shilpa Vishal Mane (Wishbon Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available